To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

May 16, 2024

WA State Brain Tumor Awareness Day

Jay Inslee, Governor of the state of Washington, has proclaimed May 18th, 2024 as Brain Tumor Awareness Day. This day recognizes all patients - pediatric and adults - with primary, secondary and/or CNS brain tumors, as well as families, caregivers, healthcare providers, and researchers who serve this patient population.

The National Cancer Institute estimates an incidence of seven new brain tumor diagnoses for every 100,000 Washingtonians and approximately 18,500 people die annually due to a brain tumor or other center nervous system (CNS) tumor in the United States. Brain tumors significantly impact everything for a patient and their loved ones and are often deadly, including quality of life for those who survive.

iStock 1289162155 small
doctor with patient

Despite the number of people diagnosed each year with a brain tumor, there are only a small number of drugs or devices for treatment approved by the U.S. Food and Drug Administration and there has never been a treatment developed and approved specifically for pediatric brain tumors. To support the End Brain Cancer Initiative's continued Advocacy and Awareness work, please consider making a philanthropic gift at

To celebrate and create more awareness for WA State’s Brain Tumor Awareness Day, the End Brain Cancer Initiative is hosting our Know All Your Treatment Options (KAYTO) 2024 online webinar on May 17th. We will also present our annual National HOPE Award at this event, a patient disease education, awareness, and outreach initiative sponsored by Novocure, to this year’s 2024 recipient.

KAYTO 2024 Presenting Sponsors

Gamma Tile Official Logo - 2024
KiyateclogovBRIGHT 1920w.jpg 1

Register at button below to receive access to this free online event!

EBCI Happy cancer patient woman with hat e1665030951309

Sponsor logos

Hand holding cell phone displaying app

MORE Meetings, Events, Disease Education Education and Resources


Scan or click the QR code to download the App now!


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram